Journal article

PPM1D Mosaic Truncating Variants in Ovarian Cancer Cases May Be Treatment-Related Somatic Mutations

Paul DP Pharoah, Honglin Song, Ed Dicks, Maria P Intermaggio, Patricia Harrington, Caroline Baynes, Kathryn Alsop, Natalia Bogdanova, Mine S Cicek, Julie M Cunningham, Brooke L Fridley, Aleksandra Gentry-Maharaj, Peter Hillemanns, Shashi Lele, Jenny Lester, Valerie McGuire, Kirsten B Moysich, Samantha Poblete, Weiva Sieh, Lara Sucheston-Campbell Show all

Journal of the National Cancer Institute | OXFORD UNIV PRESS INC | Published : 2016

Grants

Awarded by Cancer Research UK


Awarded by National Institutes for Health


Awarded by National Health & Medical Research Council of Australia (NHMRC)


Awarded by US Army Medical Research and Materiel Command


Awarded by The Francis Crick Institute


Awarded by NATIONAL CANCER INSTITUTE


Funding Acknowledgements

This work was funded by the Cancer Councils of New South Wales, Victoria, Queensland, South Australia and Tasmania, the Cancer Foundation of Western Australia, Cancer Research UK (C315/A2621, C490/A10119, C490/A10124, C490/A16561, C490/A6187, C1005/A12677, C1005/A6383, C1005/A7749), the Eve Appeal (The Oak Foundation), the National Institutes for Health (P30CA014089, P30CA016056, P30CA15083, P50CA136393, P50CA159981, R01CA122443, R01CA178535, R01CA61107, R01CA152990, and R01CA086381), the National Health & Medical Research Council of Australia (NHMRC; ID400413, ID400281), the Pomeranian Medical University, Queensland Cancer Fund, Roswell Park Cancer Institute Alliance Foundation, the Rudolf Bartling Foundation, the UK Department of Health, the UK National Institute for Health Research Biomedical Research Centres at the University of Cambridge and at the University College London Hospitals, and the US Army Medical Research and Materiel Command (DAMD17-01-1-0729).